Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): CDC Grants for Public Health Research Dissertation (Panel A-1), Program Announcement (PAR) 07-231, 40877-40878 [E8-16193]
Download as PDF
<![CDATA[
40877
Federal Register / Vol. 73, No. 137 / Wednesday, July 16, 2008 / Notices
health impacts of exposure to
contaminated water at Camp Lejeune.
The Act requires the survey to be
developed within 120 days of enactment
and to be conducted within one year of
enactment.
Additionally, in 2005, a panel of
independent scientists convened by
ATSDR to explore opportunities for
conducting additional health studies at
Camp Lejeune recommended that the
agency:
• Identify cohorts of individuals with
potential exposure, including adults
who lived on base; adults who resided
off base, but worked on base; children
who lived on base; and those who may
have been exposed while in utero; and
• Conduct a feasibility assessment to
address the issues involved in planning
future studies of mortality, cancer
incidence, and other health outcomes of
interest at the base.
In response, ATSDR prepared a report
on the feasibility of conducting future
epidemiological studies at the base.
ATSDR determined that available
databases could be used to identify
adults who lived at the base or civilians
who worked at the base during the
period when drinking water was
contaminated with volatile organic
compounds (VOCs).
In addition to questions on cancers,
the health survey will include questions
miscarriages, the survey will not request
information to facilitate medical record
confirmation of this adverse outcome.
For cancers, state of diagnosis will also
be obtained to facilitate acquisition of
cancer registry data. Self-reported
cancers and other diseases will be
confirmed by medical records or cancer
registrations. To facilitate medical
record confirmation, the participant will
be asked to provide a copy of the
medical record to ATSDR or to sign a
medical records release form allowing
ATSDR to gain access to the medical
record. The survey will also collect
information on residential history on
base, occupational history, and
information on several risk factors (e.g.,
socio-economic status, demographics,
smoking, alcohol consumption, etc). A
space will also be provided so that the
respondent can report other disease
conditions. The collected information
will be used to assign exposure status
and to assess potential confounding.
To improve the credibility of the
study, it is necessary to include an
external, unexposed comparison group,
similar in all respects to the Marines
and civilian workers at Camp Lejeune
except for exposure to VOCcontaminated drinking water.
There are no costs to the respondents
other than their time.
on non-fatal diseases that can be
confirmed by medical records and are
known or suspected of being associated
with solvent exposures.
This project proposes to examine the
relationship between medically
confirmed cancers and
trichloroethylene—(TCE) or
perchloroethylene—(PCE) contaminated
drinking water by mathematically
modeling the exposure to contaminated
drinking water while living or working
at Camp Lejeune.
The relationship between the
following non-fatal diseases that can be
confirmed by medical records and TCEor PCE-contaminated drinking water
will also be examined: Parkinson’s
disease, kidney failure and other severe
kidney diseases, severe liver diseases,
lupus, aplastic anemia, TCE-related skin
disorders, and scleroderma. In addition,
the health survey will include questions
on miscarriages occurring to women
who were pregnant while residing or
working on base.
The health survey will request
information about the type of cancer or
non-fatal, non-cancer disease, date of
diagnosis, hospital of diagnosis, and
doctor who diagnosed the disease to
facilitate the acquisition of medical
record confirmation. Because medical
records are usually unavailable for
ESTIMATED ANNUALIZED BURDEN HOURS
No. of
respondents
Respondents
No. of
responses per
respondent
Average
burden per
response
(in hours)
Total burden
(in hours)
Former active duty marines and navy personnel—Camp Lejeune .................
Former civilian workers—Camp Lejeune .........................................................
Former dependents (now all adults)—Camp Lejeune .....................................
Former active duty marines and navy personnel—Camp Pendleton (comparison group) ..............................................................................................
Former civilian workers—Camp Pendleton (comparison group) .....................
136,500
5,200
14,300
1
1
1
45/60
45/60
45/60
102,375
3,900
10,725
32,500
6,500
1
1
45/60
45/60
24,375
4,875
Total ..........................................................................................................
........................
........................
........................
146,250
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4163–18–P
mstockstill on PROD1PC66 with NOTICES
Dated: July 1, 2008.
Maryam I. Daneshvar,
Reports Clearance Officer, Centers for Disease
Control and Prevention.
[FR Doc. E8–16174 Filed 7–15–08; 8:45 am]
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): CDC Grants for
Public Health Research Dissertation
(Panel A–1), Program Announcement
(PAR) 07–231
Centers for Disease Control and
Prevention
Correction: This notice was published
in the Federal Register on June 12,
2008, Volume 73, Number 114, page
33434. The title should read as follows:
Disease, Disability, and Injury
VerDate Aug<31>2005
17:44 Jul 15, 2008
Jkt 214001
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
Prevention and Control Special
Emphasis Panel (SEP): CDC Grants for
Public Health Research Dissertation
(Panel A–2), Program Announcement
(PAR) 07–231.
Contact Person for More Information:
Sheree Marshall Williams, Ph.D., M.Sc.,
Scientific Review Administrator, CDC,
1600 Clifton Road, NE., Mailstop D72,
Atlanta, GA 30333, Telephone (404)
639–4896.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
E:\FR\FM\16JYN1.SGM
16JYN1
40878
Federal Register / Vol. 73, No. 137 / Wednesday, July 16, 2008 / Notices
and the Agency for Toxic Substances
and Disease Registry.
Dated: July 9, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–16193 Filed 7–15–08; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): CDC Grants for
Public Health Research Dissertation
(Panel A–2), Program Announcement
(PAR) 07–231
Correction: This notice was published
in the Federal Register on June 12,
2008, Volume 73, Number 114, page
33435. The title should read as follows:
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): CDC Grants for
Public Health Research Dissertation
(Panel A–3), Program Announcement
(PAR) 07–231.
Contact Person for More Information:
Sheree Marshall Williams, Ph.D., M.Sc.,
Scientific Review Administrator, CDC,
1600 Clifton Road, NE., Mailstop D72,
Atlanta, GA 30333, Telephone (404)
639–4896.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Dated: July 9, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–16194 Filed 7–15–08; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
mstockstill on PROD1PC66 with NOTICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
VerDate Aug<31>2005
17:00 Jul 15, 2008
Jkt 214001
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4)) and 552b(c)(6), Title 5
U.S.C., as amended. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Nephrology Applications PAR06113.
Date: July 28–29, 2008.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Ryan G. Morris, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4205,
MSC 7814, Bethesda, MD 20892, 301–435–
1501, morrisr@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; NAED
Reviewer Conflicts.
Date: July 28, 2008.
Time: 1:30 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Eduardo A. Montalvo,
PhD, Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5212,
MSC 7852, Bethesda, MD 20892, (301) 435–
1168, montalve@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Kidney
Dialysis, Monitoring and Therapeutics Small
Business Emphasis Panel.
Date: August 6, 2008.
Time: 1:30 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Krystyna E. Rys-Sikora,
PhD, Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4016J,
MSC 7814, Bethesda, MD 20892, 301–451–
1325, ryssokok@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Deferred
UKGD Applications.
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
Date: August 8, 2008.
Time: 4 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Ryan G. Morris, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4205,
MSC 7814, Bethesda, MD 20892, 301–435–
1501, morrisr@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: July 3, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–15819 Filed 7–15–08; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; AIDS
Vaccines, Immunology and Pathogenesis.
Date: July 14, 2008.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Ranga V. Srinivas, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5222,
MSC 7852, Bethesda, MD 20892, (301) 435–
1167, srinivar@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
E:\FR\FM\16JYN1.SGM
16JYN1
]]>Agencies
[Federal Register Volume 73, Number 137 (Wednesday, July 16, 2008)]
[Notices]
[Pages 40877-40878]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-16193]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): CDC Grants for Public Health Research
Dissertation (Panel A-1), Program Announcement (PAR) 07-231
Correction: This notice was published in the Federal Register on
June 12, 2008, Volume 73, Number 114, page 33434. The title should read
as follows: Disease, Disability, and Injury Prevention and Control
Special Emphasis Panel (SEP): CDC Grants for Public Health Research
Dissertation (Panel A-2), Program Announcement (PAR) 07-231.
Contact Person for More Information: Sheree Marshall Williams,
Ph.D., M.Sc., Scientific Review Administrator, CDC, 1600 Clifton Road,
NE., Mailstop D72, Atlanta, GA 30333, Telephone (404) 639-4896.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both CDC
[[Page 40878]]
and the Agency for Toxic Substances and Disease Registry.
Dated: July 9, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E8-16193 Filed 7-15-08; 8:45 am]
BILLING CODE 4163-18-P
